Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Medicine, Cystic fibrosis, Pseudomonas aeruginosa, Antibiotics, Ivacaftor, and Biology.
Cardiovascular function in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: A cross-sectional, observational, single-centre study
WS08.03Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor/tezacaftor/ivacaftor therapy
Standards for the care of people with cystic fibrosis (CF); Planning for a longer life
Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosis
Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium
Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention
G385 RATNO - Reducing Antibiotic Tolerance using Nitric Oxide in Cystic Fibrosis: report of a proof of concept clinical trial
Complexity, Temporal Stability, and Clinical Correlates of Airway Bacterial Community Composition in Primary Ciliary Dyskinesia
Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience
Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis